Articles tagged with Colorectal Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A recent Mayo Clinic study found that using high-definition imaging tools during screening colonoscopies can increase adenoma detection rates by up to 25% in women and 41% in men. The study suggests that national benchmarks for detecting polyps may be too low, especially when using advanced technology.
The Cleveland Clinic has developed a clinical screening program for Lynch syndrome, the most common genetic cause of colon cancer in adults. The program uses universal screening for colorectal cancers surgically removed at the clinic and successfully referred individuals whose tumors screen positive to genetics professionals.
Researchers at UT MD Anderson Cancer Center found that tumor endothelial cells can trigger changes in cancer cells, making them more resistant to chemotherapy and more likely to spread. This signaling process involves the activation of the Notch molecular pathway and may be targeted by existing drugs under development.
Researchers found that tailored phone interventions and mailings significantly increased colorectal cancer screening rates. Patients who received these interventions were almost three times more likely to undergo screening six months later compared to those with no intervention.
Researchers discovered that grape seed extract selectively targets advanced colorectal cancer cells with fewer genetic mutations, leading to increased effectiveness in treatment. The compound induces oxidative stress and programmed cell death, reversing its effects when antioxidants are present.
A study found that including CTC as a HEDIS-compliant colorectal cancer screening test can increase overall screening rates. The analysis used demographic and healthcare utilization data to demonstrate the potential impact of adding CTC as a qualifying test for HEDIS CRC screening metrics.
A new study found that fingolimod, a multiple sclerosis drug, could potentially eliminate or reduce the progression of colitis-associated cancer by decreasing inflammation and blocking key signaling molecules. The researchers used animal models to demonstrate the efficacy of the drug in reducing CAC development and progression.
A Mayo Clinic-developed two-hour training course increased adenoma detection rates among experienced endoscopists, lowering colorectal cancer risk. The study found that even non-academic physicians can benefit from the training.
A recent study published in The BMJ suggests that cancer screening for patients with a life expectancy of less than 10 years may not be beneficial. The researchers analyzed data from five breast and four colorectal cancer trials, finding that the benefits of screening often outweigh the risks. However, they also emphasize that individu...
Researchers at Vanderbilt University Medical Center have identified three new genetic variants linked to an increased risk of colorectal cancer. The study, published in Nature Genetics, provides new insight into the biology of the disease and could lead to new therapeutic targets.
A new analysis suggests that individuals with Lynch syndrome, who have a high risk of developing colorectal and other cancers, may lower their risk by adopting an eating pattern low in snack foods. The study found that those with higher intakes of snack foods were twice as likely to develop precancerous lesions.
Researchers found that patients with a family history of colorectal cancer are more likely to develop tumors with low-level methylation of LINE-1, a molecular sign associated with an aggressive form of the disease. Testing for this sign may help identify patients in need of aggressive treatment and inform familial cancer-risk assessments.
Researchers have developed a simple breath analysis technique that can screen for colorectal cancer with an accuracy of over 75%. The method analyzes volatile organic compounds in exhaled breath, which are different in patients with cancer.
A cost-effectiveness analysis found that KRAS testing is cost-saving, while BRAF testing offers additional savings. The study suggests that molecular testing primarily generates cost savings by identifying nonresponders, rather than improving survival.
Scientists have discovered that a gene switch regulates the expression of genes and promotes cancer development, according to a study published in Science. The study found that removing a specific region containing a genetic variant increased resistance to tumor formation in mice.
A study led by Vanderbilt University Medical Center researchers found that regular green tea consumption is associated with a reduced risk of digestive system cancers, particularly for stomach/esophagus and colorectal cancers. Women who drank green tea at least three times a week had a 17-21% lower risk compared to non-tea drinkers.
A recent study found that over one-third of cancer survivors in the US experience physical and mental health problems after treatment. The study identified groups at higher risk for long-term quality-of-life issues, with those with certain types of cancer facing significant challenges.
A nationwide study led by Dana-Farber Cancer Institute found that 69% of advanced lung cancer and 81% of advanced colorectal cancer patients believe chemotherapy can cure their disease. However, skilled clinicians can set realistic expectations without losing hope or trust.
A recent study from Stanford University School of Medicine found that increased use of colonoscopy screening may be responsible for the significant decrease in colorectal cancer incidence over the past decade. The study analyzed data from over 2 million patients and found a correlation between Medicare's extension of colonoscopy covera...
Thomas Jefferson University researcher Scott Waldman receives a $1.2 million NCI grant to investigate the relationship between obesity and cancer, with a focus on guanylyl cyclase C hormone receptor. The research aims to understand how obesity increases colorectal cancer risk and potentially identify a therapeutic target.
Patients with chronic constipation may be at higher risk of developing colorectal cancer and benign neoplasms. The study found a consistent association between chronic constipation and the development of these conditions.
Researchers presented new insights on esophageal cancer prevention with statins, which showed a 30% reduction in incidence. Additionally, mortality rates from upper gastrointestinal bleeding decreased by 45%, while novel treatments for GERD and IBS were introduced, including electrical stimulation of the esophagus.
Two studies suggest that women under 50 with endometrial cancer have a four-fold increased risk of colorectal cancer, while extended family members of patients with colorectal cancer also show an elevated risk. Additionally, obesity and gender may impact adenoma detection rates.
African-Americans and those living in high-poverty areas were more likely to present with an emergency diagnosis, indicating missed opportunities for screening. The study highlights the need to address these disparities to reduce mortality from colorectal cancer.
A randomized trial of over 14,000 male physicians found that long-term daily multivitamin use resulted in a modest but statistically significant reduction in cancer incidence. The study suggests that multivitamins may have a greater benefit on more clinically relevant cancer diagnoses.
A new noninvasive test measures DNA changes and fecal blood to detect precancerous lesions, showing high detection rates for cancers and precursors. The test achieved 98% sensitivity for all cancers and 83% for precursors with high-grade dysplasia.
A study of 5,442 female health professionals found that combined folic acid, vitamin B6, and vitamin B12 supplements did not reduce the risk of colorectal adenomas. No association was seen between supplement intake and cancer risk despite previous observational studies suggesting potential protective effects.
Researchers have identified a new function of the IKKalpha enzyme variant in colorectal cancer progression. This breakthrough could lead to the design of targeted drugs that inhibit this specific form of the enzyme, reducing harm to healthy cells.
New studies report that robotic-assisted bladder procedures and minimally invasive colorectal operations can improve outcomes in older patients. Robotic-assisted bladder surgery, which was previously not offered to patients over 80, showed a seven-day hospital stay and only three complications within 90 days.
The American Gastroenterological Association and other GI societies have issued updated guidelines for colonoscopy surveillance after screening and polypectomy. These recommendations support previous guidelines, addressing areas such as the need to repeat colonoscopies every 10 years for average-risk patients with a clean exam result.
Evidence suggests aspirin may lower colorectal cancer risk by 24% and mortality rates by 35%, but concerns remain about side effects. The ESMO Congress debates whether aspirin should be used for chemoprevention of colorectal adenoma/cancer.
A new database compiled by researchers has linked 16 independent gene variants to an increased risk of colorectal cancer. The database, known as CRCgene, provides valuable insights for furthering research on the disease.
A new $13 million project at Fred Hutchinson Cancer Center aims to identify genetic links to colorectal cancer using next-generation sequencing. The study will reveal entire genome sequences of a subset of samples and capture rare variants that could lead to improved drug development and disease prevention.
The study found that RRM2 overexpression is positively correlated with invasive properties of CRC cells. Silencing RRM2 inhibited hyperplasia and invasiveness, indicating its role in CRC progression. Additionally, RRM2 depletion increased UV sensitivity, suggesting a facilitating factor in DNA damage repair.
A study using narrow band imaging found high accuracy for predicting polyp type and suggests leaving distal colon hyperplastic polyps in place with acceptable accuracy. The technology improved visualization of mucosal characteristics, enabling real-time assessment of polyp type.
A drug trial found that TAS-102 improved survival time, reduced risk of death, and controlled disease progression in patients with advanced, inoperable colorectal cancer. Patients treated with TAS-102 had a median overall survival of 9 months, compared to 6.6 months for the placebo group.
Researchers have discovered a link between reactivated R-spondin proteins and colon cancer development, potentially leading to more personalized therapies. The discovery involves gene mutations that trigger cell proliferation in the colon.
Recent studies suggest that colonoscopy-related factors are more predictive of colorectal cancer risk than polyp characteristics. High levels of lead exposure also pose significant health risks, even at low blood lead levels. Meanwhile, a new lung cancer screening model shows high accuracy in identifying patients who will benefit from ...
A recent mouse study found a clear link between inflammation in the gut and changes in bacterial communities. The research team discovered that inflammation leads to simplification of diverse microbial communities, allowing new bacteria to establish footholds, such as E. coli, which promotes tumor formation.
A systematic approach to improve screening rates for colorectal cancer resulted in a fourfold increase in screening among low-risk individuals. The protocol, which included introductory phone calls and mailed testing kits, saw CRC screening rates jump from 47 to 72 percent in three years.
A Swiss study found that colonoscopy with polypectomy significantly reduces colorectal cancer incidence and mortality. The screened group had 12 cases, while the non-screened group had 213 cases, resulting in lower cancer-related death rates.
The study found that colon and rectal cancers have nearly indistinguishable genomic alterations, leading researchers to group them as one type of cancer. Several recurrent genetic errors contribute to colorectal cancer, with potential targets for treatment identified including genes ERBB2 and IGF2.
A study found that inactivating the epidermal growth factor receptor increases colorectal tumors, while promoting its activity reduces inflammation and tumor development. This suggests that increasing epidermal growth factor activity in IBD patients may lower their long-term cancer risk.
The number of Americans with a history of cancer is expected to reach 18 million by 2022, with 45% of survivors aged 70 or older. Improved cancer survival rates have led to the growth in survivor prevalence despite decreasing cancer incidence rates.
A study using PET/CT imaging with F-18 FDG reveals that molecular imaging biomarkers can predict the effectiveness of radiochemotherapy for locally advanced rectal cancer. This improvement in treatment planning could lead to more effective and cost-efficient care.
A new study suggests that some physicians would recommend colorectal cancer screening for 80-year-old patients with advanced lung cancer who would not benefit from the procedure. Physicians were found to be more likely to recommend invasive tests like colonoscopy rather than non-invasive ones.
Scientists from Ludwig Institute for Cancer Research (LICR) present promising research findings at ASCO. The studies aim to advance the scientific dialogue and potentially lead to new cancer treatments.
Researchers found that patients prefer colonoscopy over computed tomography colonography, despite its more invasive nature. The study highlights the importance of a patient's experience in the process of colonoscopy and suggests that colonoscopy is the preferred test for screening average-risk patients.
A large population-based randomized trial found that flexible sigmoidoscopy screening reduced overall colorectal cancer mortality by 26% and incidence by 21% compared to usual care. The test detected 24% of diagnosed cancers with fewer side effects than colonoscopy.
A web-based video instructional program significantly improves patient compliance with colonoscopy screenings, cutting no-show rates by up to 40%. The study found that patients who watched the video were more likely to arrive prepared and cancel appointments less frequently, leading to better outcomes for cancer detection and treatment.
Researchers from the University of Southampton have developed a groundbreaking study to investigate the experiences and needs of people after primary treatment of colorectal cancer. The CREW study aims to inform healthcare providers about what helps or hinders rapid and effective recovery, with over 1,000 patients recruited.
Current colorectal cancer screening guidelines for individuals with first-degree relatives having precancerous colon polyps are not based on well-designed studies. A new systematic review calls for new research to measure the risk and identify modifying factors.
Researchers found no link between beta blocker use and colorectal cancer risk, even after considering patient characteristics. Long-term use or subtypes of beta blockers showed no reduction in colorectal cancer risk.
A new study finds that differences in screening account for 42% of the observed disparity in colorectal cancer incidence and 19% of disparity in mortality between blacks and whites. Equal access to care could substantially reduce racial disparities in colorectal cancer rates.
Researchers at Dartmouth's Geisel School of Medicine have identified variant enhancer loci (VELs) that can turn genes on or off in colorectal cancer. The discovery provides clues about the disease's development and could lead to new therapeutic targets.
A randomized clinical trial found that patients given a choice between fecal occult blood testing (FOBT) and colonoscopy completed CRC screening more often than those assigned to colonoscopy alone. Racial/ethnic differences in screening completion rates were observed, with African-Americans having the lowest rate.
Researchers at Fox Chase Cancer Center have developed a new approach to overcome drug resistance in colorectal cancer patients. Their novel drug, ARI-4175, has shown promise in extending survival by enlisting the body's own immune system to reject tumors.
A Mayo Clinic study identified two genes that are optimal targets for a new noninvasive colon cancer test, developed by Mayo Clinic and Exact Sciences Corporation. The test uses stool sample analysis to detect specific DNA changes associated with cancer development.
Researchers developed a multimarker molecular stool test that is highly sensitive to early-stage cancers and precancerous adenomas. The test was unaffected by variables such as age, sex, race, alcohol consumption, tobacco use, body mass, and medication use.
Researchers have identified a new population of intestinal stem cells marked by the protein Lrig1, which appears to be relatively quiescent and acts as a tumor suppressor. This finding may hold clues to the origin of colorectal cancer and could lead to better understanding of its development and therapeutic targets.